Spain· ES:73664
QUINAPRIL/HIDROCLOROTIAZIDA AUROVITAS 20 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
A medicinal product containing quinapril + hidroclorotiazida, registered in Spain by Aurovitas Spain, S.A.U..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- quinapril + hidroclorotiazida
- Manufacturer
- Aurovitas Spain, S.A.U.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- June 3, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Quinapril + hidroclorotiazida in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAccupro CompPfizer Oy
- United StatesQuinapril and HydrochlorothiazideChartwell RX, LLC
- United KingdomAccuretic 10mg/12.5mg tabletsMawdsley-Brooks & Company Ltd
- CanadaAURO-QUINAPRIL HCTZAURO PHARMA INC
- ItalyQUINAPRIL E IDROCLOROTIAZIDE MYLAN GENERICSMYLAN S.P.A.
- FranceACUILIX 20 mg/12,5 mg, comprimé pelliculé sécablePFIZER HOLDING FRANCE
- GermanyQuinaplusStadapharm Gmbh
- SwedenKinoprilam comp 10 mg/12,5 mg Filmdragerad tablettSTADA Arzneimittel AG
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Germany · Quinaplus, Quinapril/Hydrochlorothiazid Aurobindo
- France · Acuilix, Quinapril Hydrochlorothiazide Eg
- Italy · Quinapril E Idroclorotiazide Mylan Generics, Quinapril Idroclorotiazide Aurobindo
- Netherlands · Quinapril/Hct Cf
- Sweden · Kinoprilam Comp
- Slovakia · Stadapress
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cae71c24-d59d-44a6-ada4-3b52edd2cf5d GET /v1/drugs/cae71c24-d59d-44a6-ada4-3b52edd2cf5d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1301608800000,\"rev\":1699460600000}",
"nregistro": "73664",
"substance": "quinapril + hidroclorotiazida"
}See everything about quinapril + hidroclorotiazida.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.